Moustiatse Adelia MD is categorized under Internal Medicine Practitioners in Jersey City, NJ and active since 2007.
Moustiatse Adelia MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Adelia Moustiatse at the company’s single location by writing to 2555 John F Kennedy Boulevard, Jersey City, New Jersey NJ 07304 or by phoning (201) 761-0717. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Moustiatse Adelia MD |
Contact Person: | Adelia Moustiatse |
Address: | 2555 John F Kennedy Boulevard, Jersey City, New Jersey 07304 |
Phone Number: | (201) 761-0717 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Moustiatse Adelia MD was started in 2007 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Adelia Moustiatse for inquiries that concern Moustiatse Adelia MD by calling the company number (201) 761-0717, as your correspondence is most welcome. Additionally, the physical location of the single location of Moustiatse Adelia MD can be found at the coordinates 40.724395,-74.074094 as well as the street address 2555 John F Kennedy Boulevard in Jersey City, New Jersey 07304.
For its online presence, you may visit Moustiatse Adelia MD’s website at and engage with its social media outlets through on Twitter and on Facebook.